Clinical Study

Novel Models for the Prediction of Left Atrial Appendage Thrombus in Patients with Chronic Nonvalvular Atrial Fibrillation

Table 1

Demographic, clinical, and echocardiographic characteristics of patients with nonvalvular atrial fibrillation.

CharacteristicWith LAAT (n = 35)Without LAAT (n = 109) value

Female sex6 (11.7%)24 (22%)<0.001
Age, years72.4 ± 11.568.4 ± 10.60.20
BMI (kg/m2)22.1 ± 2.122.5 ± 3.10.01
Heart rate (bpm)76.3 ± 10.578.4 ± 11.50.33
Heart failure10 (28.6%)31 (28.4%)<0.001
Hypertension29 (82.9%)70 (64.2%)<0.001
Diabetes type 24 (11.4%)17 (15.6%)<0.001
History of ischemic stroke16 (45.7%)26 (23.9%)<0.001
Vascular disease7 (20%)20 (18.3%)<0.001
CHA2DS2-VASc score3.63 ± 2.03.0 ± 1.60.08
LV diastolic diameter (mm)50.4 ± 7.249.7 ± 8.50.31
LV systolic diameter (mm)36.8 ± 8.235.3 ± 9.30.29
LV diastolic volume (mL)124.7 ± 43121.3 ± 51.60.47
LV systolic volume (mL)62 ± 34.858.2 ± 4.040.36
LV ejection fraction (%)47.1 ± 11.656 ± 13.60.16

Data represent frequency (percentage) or mean ± standard deviation. BMI: body mass index; LAAT: left atrial appendage thrombus; LV: left ventricle.